Heartflow develops AI-powered software for non-invasive diagnosis and management of coronary artery disease, the world's leading cause of death, by applying deep learning and computational fluid dynamics to analyze heart imaging without requiring invasive procedures. The platform's core offering is FFRCT Analysis, which identifies clinically significant disease and reduces unnecessary catheterizations, along with complementary products for plaque assessment, image analysis, and procedural planning that generate revenue through a pay-per-click model as physicians access diagnostic reports. Deployed across hundreds of accounts in the United States with strong reimbursement coverage under dedicated medical codes, Heartflow operates through a direct sales organization and generates recurring revenue from expanding utilization at existing customers and new account acquisition in underserved markets.